作者
Antoine Tabarin,Guillaume Assié,Pascal Barat,F. Bonnet,J. F. Bonneville,Françoise Borson‐Chazot,Jérôme Bouligand,A. Boulin,Thierry Brue,Philippe Caron,Frédéric Castinetti,Olivier Chabre,Philippe Chanson,J.-B. Corcuff,Christine Cortet,Régis Coutant,Anthony Dohan,Delphine Drui,Stéphanie Espiard,Delphine Gaye,Solenge Grunenwald,Laurence Guignat,Elif Hindié,Frédéric Illouz,Peter Kamenický,Henri Lefebvre,Agnès Linglart,Lætitia Martinerie,M.O. North,Marie Laure Raffin-Samson,I. Raingeard,Gérald Raverot,Véronique Raverot,Yves Reznik,David Taïeb,Delphine Vezzosi,Jacques Young,Jérôme Bertherat
摘要
Cushing's syndrome is defined by prolonged exposure to glucocorticoids, leading to excess morbidity and mortality. Diagnosis of this rare pathology is difficult due to the low specificity of the clinical signs, the variable severity of the clinical presentation, and the difficulties of interpretation associated with the diagnostic methods. The present consensus paper by 38 experts of the French Society of Endocrinology and the French Society of Pediatric Endocrinology and Diabetology aimed firstly to detail the circumstances suggesting diagnosis and the biologic diagnosis tools and their interpretation for positive diagnosis and for etiologic diagnosis according to ACTH-independent and -dependent mechanisms. Secondly, situations making diagnosis complex (pregnancy, intense hypercortisolism, fluctuating Cushing's syndrome, pediatric forms and genetically determined forms) were detailed. Lastly, methods of surveillance and diagnosis of recurrence were dealt with in the final section.